About MITOMED PHARMA, INC.
Mitomed Pharma is developing next-generation, highly innovative cancer treatments with potential to be best-in-class, targeting a critical mechanism inside tumor cells that enables them to proliferate. Their approach involves disrupting a key protein-protein interaction in mitochondria to kill cancer cells.
Developing next-generation cancer treatmentsDesigning dual specificity cancer therapeuticsTargeting previously unknown vulnerabilities in cancer cellsSystemically administered drugs that selectively enter cancer cellsDisrupting key regulators of iron acquisition and reactive oxygen speciesAdvancing novel class of cancer therapeutics
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MITOMED PHARMA, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.